Racial differences in secondary treatment pathways and survival in localized prostate cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 20:16 ET (27-Oct-2026 00:16 GMT/UTC)
AMHERST, Mass. — Bladder cancer, one of the 10 most common cancers, is notoriously difficult to treat, with up to 80% of patients experiencing a post-treatment recurrence. A common practice is to surgically remove the entire bladder, but this leaves the patient incontinent. Now, a research effort led by the University of Massachusetts Amherst has been awarded a five-year grant providing up to $3.45 million from the National Institutes of Health to develop a new way to prevent the cancer’s recurrence, without removing the organ or aggressive repeated treatments.
Summary
- Long-term health of Francophone and Allophone populations benefit from receiving language-concordant physician care; - Language concordance is key to improving long-term survival in an increasingly multilingual Canadian population; - Research analyzed over 50,000 Canadian patients over 15 years.